Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ghana | 13 | 2021 | 333 | 0.920 |
Why?
|
Panax | 3 | 2001 | 27 | 0.500 |
Why?
|
Women's Health | 4 | 2011 | 2081 | 0.390 |
Why?
|
Breast Self-Examination | 1 | 2011 | 33 | 0.380 |
Why?
|
Faculty, Medical | 3 | 2004 | 1225 | 0.370 |
Why?
|
Breast Neoplasms | 21 | 2021 | 21069 | 0.360 |
Why?
|
Self Concept | 2 | 2007 | 1039 | 0.360 |
Why?
|
Attitude to Health | 3 | 2011 | 2020 | 0.350 |
Why?
|
Health Status | 4 | 2012 | 4085 | 0.330 |
Why?
|
Urban Population | 2 | 2007 | 2040 | 0.310 |
Why?
|
Overweight | 2 | 2018 | 2444 | 0.310 |
Why?
|
Plants, Medicinal | 2 | 1999 | 165 | 0.290 |
Why?
|
Hypertension | 5 | 2019 | 8616 | 0.270 |
Why?
|
Carcinoembryonic Antigen | 6 | 1990 | 336 | 0.270 |
Why?
|
Health Status Indicators | 1 | 2011 | 967 | 0.260 |
Why?
|
Cultural Characteristics | 1 | 2007 | 250 | 0.260 |
Why?
|
Obesity | 7 | 2018 | 13082 | 0.260 |
Why?
|
Body Image | 2 | 2007 | 645 | 0.250 |
Why?
|
Career Mobility | 2 | 2004 | 261 | 0.240 |
Why?
|
Teaching | 1 | 2011 | 1170 | 0.220 |
Why?
|
Menarche | 1 | 2006 | 532 | 0.210 |
Why?
|
Physician Executives | 1 | 2004 | 140 | 0.210 |
Why?
|
BCG Vaccine | 2 | 1996 | 380 | 0.210 |
Why?
|
Sexually Transmitted Diseases | 1 | 2008 | 668 | 0.200 |
Why?
|
Melanoma, Experimental | 2 | 1996 | 555 | 0.200 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 4 | 2003 | 890 | 0.200 |
Why?
|
Small-Area Analysis | 1 | 2021 | 51 | 0.190 |
Why?
|
Hospitals, Teaching | 3 | 2021 | 1156 | 0.190 |
Why?
|
Chronic Disease | 2 | 2019 | 9351 | 0.190 |
Why?
|
Health Surveys | 5 | 2021 | 4058 | 0.180 |
Why?
|
Censuses | 1 | 2021 | 197 | 0.180 |
Why?
|
Cyclins | 1 | 2001 | 598 | 0.160 |
Why?
|
Health Promotion | 1 | 2011 | 2208 | 0.160 |
Why?
|
Mentors | 1 | 2004 | 671 | 0.150 |
Why?
|
Clothing | 1 | 2019 | 95 | 0.150 |
Why?
|
Drugs, Chinese Herbal | 1 | 1999 | 140 | 0.150 |
Why?
|
Age Distribution | 2 | 2018 | 2864 | 0.150 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2011 | 4055 | 0.140 |
Why?
|
Sampling Studies | 1 | 2018 | 610 | 0.140 |
Why?
|
Early Detection of Cancer | 1 | 2011 | 3238 | 0.140 |
Why?
|
Cost of Illness | 1 | 2006 | 1949 | 0.130 |
Why?
|
Transcriptional Activation | 1 | 2001 | 1743 | 0.120 |
Why?
|
Mastectomy | 2 | 2021 | 1848 | 0.120 |
Why?
|
Indium Radioisotopes | 3 | 1990 | 113 | 0.120 |
Why?
|
Health Behavior | 1 | 2006 | 2649 | 0.120 |
Why?
|
Tumor Cells, Cultured | 7 | 2001 | 6101 | 0.120 |
Why?
|
Patient Acceptance of Health Care | 1 | 2008 | 3230 | 0.120 |
Why?
|
Leadership | 1 | 2004 | 1393 | 0.120 |
Why?
|
Antibodies, Monoclonal | 10 | 1997 | 9239 | 0.110 |
Why?
|
Tamoxifen | 4 | 2007 | 964 | 0.110 |
Why?
|
Sex Distribution | 1 | 2018 | 2269 | 0.110 |
Why?
|
Indium | 3 | 1986 | 46 | 0.100 |
Why?
|
Socioeconomic Factors | 4 | 2021 | 7842 | 0.100 |
Why?
|
Body Mass Index | 4 | 2021 | 13042 | 0.100 |
Why?
|
Radioimmunodetection | 1 | 1992 | 45 | 0.100 |
Why?
|
Female | 37 | 2021 | 396141 | 0.100 |
Why?
|
Interleukin-2 | 2 | 1996 | 1894 | 0.100 |
Why?
|
Proto-Oncogenes | 1 | 1993 | 320 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 2 | 1993 | 1163 | 0.100 |
Why?
|
Radioimmunotherapy | 1 | 1992 | 93 | 0.100 |
Why?
|
Nicaragua | 1 | 2011 | 29 | 0.100 |
Why?
|
Cystadenocarcinoma | 1 | 1991 | 54 | 0.100 |
Why?
|
Interferon-gamma | 3 | 1997 | 3158 | 0.090 |
Why?
|
Colonic Neoplasms | 6 | 1990 | 2530 | 0.090 |
Why?
|
Cell Division | 6 | 2003 | 4466 | 0.090 |
Why?
|
Radioisotopes | 3 | 1986 | 498 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 1993 | 4520 | 0.090 |
Why?
|
Occupational Diseases | 1 | 2019 | 1456 | 0.090 |
Why?
|
Adult | 23 | 2021 | 223088 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 4 | 2007 | 1535 | 0.080 |
Why?
|
Breast Diseases | 1 | 1993 | 436 | 0.080 |
Why?
|
Sarcoma | 2 | 1993 | 1799 | 0.080 |
Why?
|
Estrogens | 1 | 1996 | 1528 | 0.080 |
Why?
|
Middle Aged | 21 | 2018 | 223016 | 0.080 |
Why?
|
Receptors, Progesterone | 1 | 1994 | 1152 | 0.080 |
Why?
|
Humans | 52 | 2021 | 765926 | 0.080 |
Why?
|
Body Size | 1 | 2012 | 460 | 0.080 |
Why?
|
DNA, Neoplasm | 5 | 1993 | 1739 | 0.080 |
Why?
|
Neoplasms, Unknown Primary | 1 | 1990 | 102 | 0.080 |
Why?
|
Cross-Sectional Studies | 5 | 2018 | 26282 | 0.080 |
Why?
|
Gene Amplification | 1 | 1993 | 1088 | 0.080 |
Why?
|
Prevalence | 4 | 2011 | 15828 | 0.070 |
Why?
|
Blood Pressure | 3 | 2021 | 8530 | 0.070 |
Why?
|
Body Weight | 1 | 2018 | 4627 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 1996 | 3592 | 0.070 |
Why?
|
Demography | 2 | 2008 | 1640 | 0.070 |
Why?
|
Contraception Behavior | 1 | 2009 | 185 | 0.070 |
Why?
|
Receptors, Estrogen | 2 | 1994 | 2242 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2001 | 12768 | 0.070 |
Why?
|
Social Conformity | 1 | 2006 | 39 | 0.070 |
Why?
|
Antigens, Surface | 1 | 1991 | 1616 | 0.070 |
Why?
|
Risk Factors | 8 | 2018 | 74850 | 0.070 |
Why?
|
Reproductive Medicine | 1 | 2007 | 96 | 0.060 |
Why?
|
Family Planning Services | 1 | 2009 | 277 | 0.060 |
Why?
|
Adolescent | 8 | 2011 | 88811 | 0.060 |
Why?
|
Mammography | 3 | 2011 | 2424 | 0.060 |
Why?
|
Contraception | 1 | 2009 | 360 | 0.060 |
Why?
|
HIV Seroprevalence | 1 | 2005 | 89 | 0.060 |
Why?
|
Flow Cytometry | 5 | 1999 | 5880 | 0.060 |
Why?
|
Radionuclide Imaging | 7 | 1990 | 1985 | 0.060 |
Why?
|
Life Expectancy | 1 | 2011 | 1247 | 0.060 |
Why?
|
Rectal Neoplasms | 4 | 1986 | 1183 | 0.060 |
Why?
|
Planning Techniques | 1 | 2004 | 81 | 0.060 |
Why?
|
Logistic Models | 1 | 2018 | 13273 | 0.050 |
Why?
|
Cancer Vaccines | 2 | 2003 | 1042 | 0.050 |
Why?
|
Genetic Counseling | 1 | 2007 | 634 | 0.050 |
Why?
|
Educational Status | 2 | 2009 | 2510 | 0.050 |
Why?
|
Mass Screening | 2 | 2019 | 5449 | 0.050 |
Why?
|
Parity | 1 | 2006 | 931 | 0.050 |
Why?
|
Aged | 12 | 2012 | 171163 | 0.050 |
Why?
|
Young Adult | 5 | 2019 | 59857 | 0.050 |
Why?
|
Antigens, Neoplasm | 1 | 1991 | 1995 | 0.050 |
Why?
|
Social Class | 2 | 2012 | 2007 | 0.050 |
Why?
|
Ovarian Neoplasms | 2 | 2007 | 4904 | 0.050 |
Why?
|
Blotting, Southern | 2 | 1993 | 772 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3430 | 0.050 |
Why?
|
Staff Development | 1 | 2004 | 231 | 0.050 |
Why?
|
Organizational Objectives | 1 | 2004 | 426 | 0.050 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 2001 | 220 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2003 | 2945 | 0.050 |
Why?
|
Proteins | 1 | 1996 | 5994 | 0.050 |
Why?
|
Physician's Role | 2 | 2004 | 925 | 0.050 |
Why?
|
Decision Making | 2 | 2006 | 3955 | 0.050 |
Why?
|
Malaria | 1 | 2011 | 1246 | 0.050 |
Why?
|
HT29 Cells | 1 | 2001 | 187 | 0.050 |
Why?
|
Anthropometry | 1 | 2006 | 1339 | 0.050 |
Why?
|
Recombinant Proteins | 3 | 1996 | 6491 | 0.050 |
Why?
|
Blotting, Northern | 2 | 1993 | 1546 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2021 | 81537 | 0.050 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 3 | 1995 | 921 | 0.040 |
Why?
|
Professional Competence | 1 | 2004 | 429 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2001 | 373 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2004 | 540 | 0.040 |
Why?
|
RNA, Neoplasm | 2 | 1993 | 745 | 0.040 |
Why?
|
Job Satisfaction | 1 | 2004 | 548 | 0.040 |
Why?
|
Primary Prevention | 1 | 2007 | 1187 | 0.040 |
Why?
|
Geography | 1 | 2021 | 651 | 0.040 |
Why?
|
Counseling | 2 | 2004 | 1551 | 0.040 |
Why?
|
Systole | 1 | 2021 | 935 | 0.040 |
Why?
|
Adenocarcinoma | 3 | 1992 | 6360 | 0.040 |
Why?
|
Diastole | 1 | 2021 | 785 | 0.040 |
Why?
|
Occupational Health Services | 2 | 2019 | 149 | 0.040 |
Why?
|
Developing Countries | 1 | 2011 | 2913 | 0.040 |
Why?
|
Behavior | 1 | 2021 | 536 | 0.040 |
Why?
|
HIV Infections | 1 | 2005 | 17531 | 0.040 |
Why?
|
Regression Analysis | 3 | 2006 | 6321 | 0.040 |
Why?
|
BRCA1 Protein | 2 | 2003 | 1155 | 0.040 |
Why?
|
Education, Medical, Continuing | 1 | 2004 | 829 | 0.040 |
Why?
|
Triglycerides | 1 | 2006 | 2440 | 0.040 |
Why?
|
Blood Glucose | 2 | 2019 | 6422 | 0.040 |
Why?
|
Menopause | 1 | 2006 | 1659 | 0.040 |
Why?
|
Plant Extracts | 1 | 2001 | 493 | 0.040 |
Why?
|
Injections, Intravenous | 2 | 1990 | 1376 | 0.040 |
Why?
|
Picibanil | 1 | 1997 | 10 | 0.040 |
Why?
|
Mobile Health Units | 1 | 2019 | 91 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2001 | 1524 | 0.040 |
Why?
|
Memory | 1 | 2007 | 2191 | 0.040 |
Why?
|
Mycobacterium bovis | 2 | 1997 | 147 | 0.040 |
Why?
|
Cholesterol | 1 | 2006 | 2902 | 0.030 |
Why?
|
Schools, Medical | 1 | 2004 | 882 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 6 | 1998 | 9373 | 0.030 |
Why?
|
Melanoma | 3 | 2003 | 5695 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2006 | 2028 | 0.030 |
Why?
|
Bangladesh | 1 | 2019 | 745 | 0.030 |
Why?
|
Age Factors | 3 | 2009 | 18382 | 0.030 |
Why?
|
Esthetics | 1 | 1998 | 327 | 0.030 |
Why?
|
Pain | 1 | 2011 | 5077 | 0.030 |
Why?
|
Linear Models | 1 | 2006 | 5873 | 0.030 |
Why?
|
Breast | 2 | 1996 | 1950 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2004 | 1404 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 1999 | 615 | 0.030 |
Why?
|
Liver Neoplasms | 3 | 1990 | 4349 | 0.030 |
Why?
|
Drug Synergism | 1 | 1999 | 1751 | 0.030 |
Why?
|
RNA | 2 | 1996 | 2716 | 0.030 |
Why?
|
RNA Helicases | 1 | 1996 | 144 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2007 | 3477 | 0.030 |
Why?
|
Interleukin-12 | 1 | 1997 | 581 | 0.030 |
Why?
|
Odds Ratio | 1 | 2006 | 9656 | 0.030 |
Why?
|
Jews | 1 | 1996 | 359 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2009 | 59496 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2004 | 2782 | 0.030 |
Why?
|
Cadherins | 1 | 1998 | 899 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2353 | 0.030 |
Why?
|
Medical Records | 1 | 2019 | 1408 | 0.030 |
Why?
|
Mice | 8 | 2003 | 81782 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2004 | 2662 | 0.030 |
Why?
|
Binding Sites | 1 | 2001 | 5999 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2006 | 12059 | 0.030 |
Why?
|
Fasting | 1 | 2019 | 1606 | 0.030 |
Why?
|
Receptor, erbB-2 | 2 | 1993 | 2592 | 0.020 |
Why?
|
Neoplasm Metastasis | 3 | 2003 | 4882 | 0.020 |
Why?
|
Education, Medical | 1 | 2004 | 1744 | 0.020 |
Why?
|
Paclitaxel | 1 | 1999 | 1726 | 0.020 |
Why?
|
Th1 Cells | 1 | 1997 | 1040 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 1997 | 993 | 0.020 |
Why?
|
Immunotoxins | 1 | 1992 | 175 | 0.020 |
Why?
|
Comorbidity | 1 | 2006 | 10575 | 0.020 |
Why?
|
Cell Cycle | 1 | 1999 | 2920 | 0.020 |
Why?
|
Mental Disorders | 1 | 2011 | 6870 | 0.020 |
Why?
|
Keratins | 1 | 1993 | 497 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 1996 | 1060 | 0.020 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 1993 | 249 | 0.020 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 1998 | 1086 | 0.020 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 1991 | 139 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2012 | 520 | 0.020 |
Why?
|
Massachusetts | 1 | 2004 | 8882 | 0.020 |
Why?
|
Lymphocytes | 1 | 1998 | 2601 | 0.020 |
Why?
|
Fibrocystic Breast Disease | 1 | 1991 | 101 | 0.020 |
Why?
|
Mice, Inbred C57BL | 4 | 1997 | 22327 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 1990 | 6958 | 0.020 |
Why?
|
Mastectomy, Radical | 1 | 1990 | 19 | 0.020 |
Why?
|
Citrates | 1 | 1990 | 130 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 2 | 2003 | 490 | 0.020 |
Why?
|
Citric Acid | 1 | 1990 | 124 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2019 | 1389 | 0.020 |
Why?
|
Genetic Engineering | 3 | 2003 | 933 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 1998 | 3599 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2004 | 3928 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 1990 | 410 | 0.020 |
Why?
|
Quality of Life | 1 | 2011 | 13463 | 0.020 |
Why?
|
Estradiol | 1 | 1996 | 1947 | 0.020 |
Why?
|
Anemia | 1 | 2019 | 1514 | 0.020 |
Why?
|
Axilla | 1 | 1991 | 615 | 0.020 |
Why?
|
Protein Kinases | 1 | 1996 | 1611 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1993 | 2470 | 0.020 |
Why?
|
Lymphatic Metastasis | 2 | 1998 | 2885 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1998 | 2838 | 0.020 |
Why?
|
Animals | 9 | 2003 | 168735 | 0.020 |
Why?
|
Mammaplasty | 1 | 1998 | 1264 | 0.020 |
Why?
|
DNA | 2 | 1993 | 7193 | 0.020 |
Why?
|
Thyroid Neoplasms | 2 | 1992 | 2354 | 0.020 |
Why?
|
Transfection | 1 | 1995 | 5738 | 0.020 |
Why?
|
Contraceptive Agents | 1 | 2009 | 147 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1999 | 10727 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2004 | 7423 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2011 | 12235 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 1996 | 1885 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 1994 | 1056 | 0.020 |
Why?
|
Male | 7 | 2019 | 363815 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 1996 | 2795 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 1990 | 2008 | 0.020 |
Why?
|
Transplantation, Autologous | 2 | 2003 | 2125 | 0.020 |
Why?
|
Risk Assessment | 1 | 2007 | 24275 | 0.020 |
Why?
|
Religion | 1 | 2009 | 375 | 0.020 |
Why?
|
Thyroid Gland | 1 | 1992 | 1168 | 0.020 |
Why?
|
Ploidies | 3 | 1992 | 287 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 1990 | 786 | 0.020 |
Why?
|
Cytokines | 2 | 1998 | 7417 | 0.010 |
Why?
|
Prognosis | 6 | 1995 | 29890 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 1990 | 1613 | 0.010 |
Why?
|
Time Factors | 1 | 2006 | 40097 | 0.010 |
Why?
|
Vaccination | 1 | 1997 | 3430 | 0.010 |
Why?
|
Pregnancy | 1 | 2006 | 30230 | 0.010 |
Why?
|
Neoplasm Staging | 3 | 1998 | 11196 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 1994 | 6838 | 0.010 |
Why?
|
Gene Expression | 2 | 1996 | 7581 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 1988 | 13446 | 0.010 |
Why?
|
Peritoneal Neoplasms | 1 | 1990 | 706 | 0.010 |
Why?
|
Cohort Studies | 1 | 2006 | 41680 | 0.010 |
Why?
|
Testis | 1 | 1986 | 782 | 0.010 |
Why?
|
Neoplasms | 1 | 1992 | 22340 | 0.010 |
Why?
|
Prospective Studies | 1 | 2007 | 54807 | 0.010 |
Why?
|
Spermatozoa | 1 | 1986 | 627 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1988 | 1227 | 0.010 |
Why?
|
Chemoprevention | 1 | 2004 | 327 | 0.010 |
Why?
|
Recurrence | 1 | 1994 | 8492 | 0.010 |
Why?
|
Dietary Fats | 1 | 1990 | 2002 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 1990 | 2390 | 0.010 |
Why?
|
Adenoma | 1 | 1992 | 2155 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 1996 | 5782 | 0.010 |
Why?
|
Medical History Taking | 1 | 2004 | 779 | 0.010 |
Why?
|
Self Report | 1 | 2012 | 3768 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1996 | 8603 | 0.010 |
Why?
|
Reoperation | 1 | 1990 | 4308 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1990 | 6306 | 0.010 |
Why?
|
Spleen | 2 | 1997 | 2294 | 0.010 |
Why?
|
Adenoviridae | 1 | 2003 | 1092 | 0.010 |
Why?
|
Radiography | 1 | 1990 | 6941 | 0.010 |
Why?
|
Lymph Nodes | 2 | 1986 | 3447 | 0.010 |
Why?
|
Learning | 1 | 2007 | 1754 | 0.010 |
Why?
|
Follow-Up Studies | 3 | 1998 | 39228 | 0.010 |
Why?
|
Nipples | 1 | 1998 | 222 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3801 | 0.010 |
Why?
|
Transcription Factors | 1 | 1996 | 12129 | 0.010 |
Why?
|
Sodium Chloride | 1 | 1998 | 578 | 0.010 |
Why?
|
Risk | 1 | 2007 | 9599 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3796 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2331 | 0.010 |
Why?
|
Breast Implants | 1 | 1998 | 411 | 0.010 |
Why?
|
Boston | 1 | 2007 | 9334 | 0.010 |
Why?
|
RNA, Double-Stranded | 1 | 1996 | 292 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 1997 | 13631 | 0.010 |
Why?
|
Base Sequence | 2 | 1996 | 12405 | 0.010 |
Why?
|
Eosinophils | 1 | 1998 | 946 | 0.010 |
Why?
|
Safety | 1 | 1998 | 1157 | 0.010 |
Why?
|
Tissue Distribution | 2 | 1988 | 2270 | 0.010 |
Why?
|
Cell Survival | 1 | 2003 | 5745 | 0.010 |
Why?
|
Population Surveillance | 1 | 1984 | 2596 | 0.010 |
Why?
|
DNA Damage | 1 | 2003 | 2462 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1994 | 915 | 0.010 |
Why?
|
Macrophages | 2 | 1998 | 5772 | 0.010 |
Why?
|
Skin Transplantation | 1 | 1998 | 1097 | 0.010 |
Why?
|
DEAD-box RNA Helicases | 1 | 1996 | 386 | 0.010 |
Why?
|
Disease Progression | 2 | 2003 | 13614 | 0.010 |
Why?
|
Carcinoma in Situ | 1 | 1998 | 777 | 0.010 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 1998 | 1104 | 0.010 |
Why?
|
Hyperplasia | 1 | 1996 | 1142 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1996 | 17596 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 1998 | 708 | 0.010 |
Why?
|
Mice, Nude | 1 | 1998 | 3608 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2003 | 8522 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2004 | 3270 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 1990 | 18292 | 0.010 |
Why?
|
Public Health | 1 | 1984 | 2680 | 0.010 |
Why?
|
Discriminant Analysis | 1 | 1990 | 222 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1997 | 2350 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 1997 | 1852 | 0.010 |
Why?
|
Family Health | 1 | 1995 | 1253 | 0.010 |
Why?
|
Mastectomy, Segmental | 1 | 1995 | 964 | 0.010 |
Why?
|
Anxiety | 1 | 2004 | 4669 | 0.010 |
Why?
|
Genetic Markers | 1 | 1996 | 2603 | 0.010 |
Why?
|
Surgical Flaps | 1 | 1998 | 1678 | 0.010 |
Why?
|
Cell Line | 1 | 2003 | 15540 | 0.010 |
Why?
|
Precancerous Conditions | 1 | 1996 | 975 | 0.000 |
Why?
|
Age of Onset | 1 | 1996 | 3343 | 0.000 |
Why?
|
Preoperative Care | 2 | 1987 | 2248 | 0.000 |
Why?
|
DNA Mutational Analysis | 1 | 1996 | 4111 | 0.000 |
Why?
|
Dendritic Cells | 1 | 1998 | 2745 | 0.000 |
Why?
|
Apoptosis | 1 | 2003 | 9505 | 0.000 |
Why?
|
Carcinoma | 1 | 1998 | 2311 | 0.000 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 1990 | 540 | 0.000 |
Why?
|
Biopsy | 1 | 1998 | 6766 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1994 | 6209 | 0.000 |
Why?
|
Phenotype | 1 | 2003 | 16714 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1988 | 20690 | 0.000 |
Why?
|
Patient Selection | 1 | 1997 | 4248 | 0.000 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1986 | 1724 | 0.000 |
Why?
|
Phospholipids | 1 | 1988 | 776 | 0.000 |
Why?
|
Romania | 1 | 1984 | 97 | 0.000 |
Why?
|
Muscle, Skeletal | 1 | 1998 | 4959 | 0.000 |
Why?
|
Treatment Outcome | 2 | 2003 | 65194 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2004 | 18074 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1996 | 11030 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1997 | 18962 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1998 | 10256 | 0.000 |
Why?
|
Immunotherapy | 1 | 1997 | 4746 | 0.000 |
Why?
|
Skin Neoplasms | 1 | 1998 | 5836 | 0.000 |
Why?
|
Survival Analysis | 1 | 1990 | 10086 | 0.000 |
Why?
|
Survival Rate | 1 | 1990 | 12822 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 1990 | 12529 | 0.000 |
Why?
|
Models, Theoretical | 1 | 1988 | 3560 | 0.000 |
Why?
|
Feeding Behavior | 1 | 1984 | 3209 | 0.000 |
Why?
|
Liver | 1 | 1986 | 7559 | 0.000 |
Why?
|
Stress, Psychological | 1 | 1984 | 4527 | 0.000 |
Why?
|
Child | 1 | 1990 | 80568 | 0.000 |
Why?
|